Meeder Asset Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-540
| Closed | -$8K | – | 1246 |
|
|
2021
Q3 | $8K | Hold |
540
| – | – | ﹤0.01% | 1743 |
|
|
2021
Q2 | $12K | Buy |
+540
| New | +$12K | ﹤0.01% | 1623 |
|
|
2020
Q2 | – | Sell |
-1,580
| Closed | -$4K | – | 2052 |
|
|
2020
Q1 | $4K | Buy |
1,580
+1,567
| +12,054% | +$3.97K | ﹤0.01% | 1846 |
|
|
2019
Q4 | $0 | Buy |
+13
| New | – | ﹤0.01% | 2239 |
|
|
2019
Q3 | – | Sell |
-1,874
| Closed | -$6K | – | 2137 |
|
|
2019
Q2 | $6K | Sell |
1,874
-726
| -28% | -$2.32K | ﹤0.01% | 1599 |
|
|
2019
Q1 | $8K | Hold |
2,600
| – | – | ﹤0.01% | 1292 |
|
|
2018
Q4 | $4K | Buy |
2,600
+243
| +10% | +$374 | ﹤0.01% | 1453 |
|
|
2018
Q3 | $6K | Buy |
2,357
+1,506
| +177% | +$3.83K | ﹤0.01% | 1281 |
|
|
2018
Q2 | $2.23K | Buy |
851
+70
| +9% | +$183 | ﹤0.01% | 1404 |
|
|
2018
Q1 | $2K | Sell |
781
-132
| -14% | -$338 | ﹤0.01% | 1365 |
|
|
2017
Q4 | $3K | Buy |
913
+719
| +371% | +$2.36K | ﹤0.01% | 1417 |
|
|
2017
Q3 | $1K | Sell |
194
-464
| -71% | -$2.39K | ﹤0.01% | 1534 |
|
|
2017
Q2 | $4K | Buy |
658
+113
| +21% | +$687 | ﹤0.01% | 1237 |
|
|
2017
Q1 | $3K | Sell |
545
-945
| -63% | -$5.2K | ﹤0.01% | 1240 |
|
|
2016
Q4 | $6K | Buy |
+1,490
| New | +$6K | ﹤0.01% | 832 |
|